Lancellotti P, Cosyns B. Highlights of acta cardiologica. Acta Cardiol. 2022; 77 (6): 469–470. doi: 10.1080/00015385.2022.2143092.
Lancellotti P, Petitjean H, Nchimi A, et al. Special issue on ischemic heart disease. Acta Cardiol. 2023; 78 (1): 1–4. doi: 10.1080/00015385.2023.2170563.
Lancellotti P. Focus on cardiometabolic risk factors. Acta Cardiol. 2023; 78 (5): 515–518. doi: 10.1080/00015385.2023.2231702.
Lancellotti P, Piette C. Special issue on atrial fibrillation. Acta Cardiol. 2023; 78 (3): 269–273. doi: 10.1080/00015385.2023.2205277.
Claeys MJ, Bondue A, Lancellotti P, et al. Summary of 2020 ESC guidelines on non-STE ACS, adult congenital heart disease, sports cardiology and atrial fibrillation. Acta Cardiol. 2022; 77 (10): 864–872. doi: 10.1080/00015385.2021.2003062.
Mei DA, Romiti GF, Boriani G. Prepare our healthcare systems to manage complexity: the case of atrial fibrillation. Acta Cardiol. 2023; 11: 1–3. doi: 10.1080/00015385.2023.2232691.
Zuin M, Rigatelli G, Bilato C. Weekend atrial fibrillation hospitalizations are associated with higher short-term mortality. Acta Cardiol. 2023; 20: 1–6. doi: 10.1080/00015385.2023.2223007.
Lancellotti P, Garbi M. Malignant mitral valve prolapse: substrates to ventricular remodeling and arrhythmias. Circ Cardiovasc Imaging. 2016; 9 (8): e005248. doi: 10.1161/CIRCIMAGING.116.005248.
Kubala M, de Chillou C, Bohbot Y, et al. Arrhythmias in patients with valvular heart disease: gaps in knowledge and the way forward. Front Cardiovasc Med. 2022; 9: 792559. eCollection 2022. doi: 10.3389/fcvm.2022.792559.
Benjanuwattra J, Kewcharoen J, Phinyo P, et al. High-risk phenotypes of arrhythmic mitral valve prolapse: a systematic review and meta-analysis. Acta Cardiol. 2023; 26: 1–8. doi: 10.1080/00015385.2023.2227487.
Abdelazeem A, Ahmed A, Curnis A, et al. Transvenous lead extraction, factors affecting procedural difficulty. Acta Cardiol. 2023; 15: 1–8. doi: 10.1080/00015385.2023.2222986.
Lancellotti P, Go YY, Nchimi A. Stress imaging versus fractional flow reserve: what comes first-the chicken or the egg? Eur Heart J. 2022; 43 (33): 3129–3131. doi: 10.1093/eurheartj/ehac287.
Kasinadhuni G, Batta A, Gawalkar AA, et al. Validity and correlation of quantitative flow ratio with fractional flow reserve for assessment of intermediate coronary lesions. Acta Cardiol. 2023; 78 (1): 91–98. doi: 10.1080/00015385.2022.2059857.
Desmet W. Will quantitative flow ratio replace fractional flow reserve in the cathlab? Commentary to "validity and correlation of quantitative flow ratio with fractional flow reserve for assessment of intermediate coronary lesions. Acta Cardiol. 2022; 77 (8): 673–673. doi: 10.1080/00015385.2022.2084820.
Jong CB, Liao MT, Lu TS, et al. Efficacy and safety of High-Dose intracoronary adenosine injection in fractional flow reserve assessment. Acta Cardiol Sin. 2022; 38: 553–563.
Boutaleb AM, Scalia A, Ghafari C, et al. Microcatheter- versus wire-based measurement of the fractional flow reserve. Acta Cardiol. 2023; 15: 1–9. doi: 10.1080/00015385.2023.2246009.
Poudineh M, Mansoori A, Sadooghi Rad E, et al. Platelet distribution widths and white blood cell are associated with cardiovascular diseases: data mining approaches. Acta Cardiol. 2023; 11: 1–12. doi: 10.1080/00015385.2023.2246199.
Lancellotti P, Postolache A, Dulgheru R. Highlights of imaging heart structure and function. Acta Cardiol. 2023; 78 (4): 383–386. doi: 10.1080/00015385.2023.2206690.
Lancellotti P, Ribeiro Coelho S, Nguyen Trung ML, et al. Special issue on heart failure. Acta Cardiol. 2023; 78 (2): 165–167. doi: 10.1080/00015385.2023.2182985.
Kersten J, Hackenbroch C, Gann P, et al. Myocardial deformation parameters assessed by CMR feature tracking in chronic heart failure: the influence of an optimal medical therapy on myocardial remodeling. Acta Cardiol. 2023; 22: 1–6. doi: 10.1080/00015385.2023.2246202.
Hayıroğlu Mİ, Çınar T, Cilli Hayıroğlu S, et al. The role of smart devices and mobile application on the change in peak VO2 in patients with high cardiovascular risk: a Sub-study of the LIGHT randomized clinical trial. Acta Cardiol. 2023; 15: 1–6. doi: 10.1080/00015385.2023.2223005.
Teperikidis E, Boulmpou A, Potoupni V, et al. Does the long-term administration of proton pump inhibitors increase the risk of adverse cardiovascular outcomes? A ChatGPT powered umbrella review. Acta Cardiol. 2023; 11: 1–9. doi: 10.1080/00015385.2023.2231299.
Allaeys T, Jongman L, Paelinck BP, et al. Endocarditis and an unexpected entry port. Acta Cardiol. 2022; 77 (6): 551–552. doi: 10.1080/00015385.2021.1902107.
Oliveira I, Bragança B, Neto A, et al. Infective endocarditis nightmare: a bold solution for a devastating scenario. Acta Cardiol. 2022; 77 (10): 970–971. doi: 10.1080/00015385.2022.2030556.
Nchimi A, Oury C, Lancellotti P. From charybdis to scylla when acute coronary syndrome complicates endocarditis. Acta Cardiol. 2023; 11;1: 1. doi: 10.1080/00015385.2023.2192154.
Van Oeteren I, Achten R, Ghekiere O, et al. Hidden in plain sight: complex tachycardias in a young thalassemia patient. Acta Cardiol. 2023; 15: 1–4. doi: 10.1080/00015385.2023.2223014.
